Theravance Biopharma Inc (NASDAQ:TBPH) has a beta value of -0.09 and has seen 1.81 million shares traded in the last trading session. The company, currently valued at $557.51M, closed the last trade at $11.15 per share which meant it gained $1.99 on the day or 21.72% during that session. The TBPH stock price is 2.24% off its 52-week high price of $10.90 and 33.27% above the 52-week low of $7.44.
The consensus among analysts is that Theravance Biopharma Inc (TBPH) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Theravance Biopharma Inc (NASDAQ:TBPH) trade information
Over the past 30 days, the shares of Theravance Biopharma Inc (NASDAQ:TBPH) have changed 7.31%.
Wall Street analysts have a consensus price target for the stock at $15, which means that the shares’ value could jump 25.67% from current levels. The projected low price target is $10.0 while the price target rests at a high of $21.0. In that case, then, we find that the current price level is -88.34% off the targeted high while a plunge would see the stock lose 10.31% from current levels.
Theravance Biopharma Inc (TBPH) estimates and forecasts
The company’s shares have gained 20.67% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 22.95% over the past 5 years. Earnings growth for 2025 is a modest 60.11% while over the next 5 years, the company’s earnings are expected to increase by 24.13%.
TBPH Dividends
Theravance Biopharma Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Theravance Biopharma Inc (NASDAQ:TBPH)’s Major holders
The top two institutional holders are MADISON AVENUE PARTNERS, LP with over 8.51 million shares worth more than $72.18 million. As of 2024-06-30, MADISON AVENUE PARTNERS, LP held 17.4603% of shares outstanding.
The other major institutional holder is WEISS ASSET MANAGEMENT LP, with the holding of over 7.46 million shares as of 2024-06-30. The firm’s total holdings are worth over $63.24 million and represent 15.2975% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Mar 31, 2025 , the former fund manager holds about 2.29% shares in the company for having 1.14 shares of worth $12.75 million while later fund manager owns 949.8 shares of worth $10.59 million as of Mar 31, 2025 , which makes it owner of about 1.90% of company’s outstanding stock.
